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Current H1N1 virus has been found to contain a unique
combination of genes from pig, bird and human flu viruses.
This peculiar recombinant influenza virus is entirely new
and has not been seen before (1). This creates an almost
universal vulnerability to infection in nearly all people.
Therefore, the emergence of H1N1 infection among
humans presents the greatest pandemic threat since the
1968 pandemic caused by H3N2 (2).However, it raises
one very important question-Is it an automutated or
genetically engineered virus for some good/bad cause ?.
Beginning in March 2009, an outbreak of influenza in
North America was found to be caused by a new strain
of influenza virus, designated Influenza H1N1 2009. On
April 9, 2009 it became apparent to public health officials
in Mexico City that an outbreak of influenza was in
progress late in the influenza season (3).On April 17, two
cases in children were also reported in California near
the Mexican border (4). The current outbreak of swine
influenza A (H1N1) evolved so rapidly that as on 29 April
2009, nine countries officially reported with confirmed
cases of swine influenza A/H1N1 infection. Of these,
Mexico, United State, Austria, Canada, Germany, Israel,
New Zealand, Spain and the United Kingdom have
reported laboratory confirmed human cases and deaths
due to rapidly progressive pneumonia, respiratory failure
and acute respiratory distress syndrome (ARDS). World
Health Organization (WHO) declared ever high stages
on its "pandemic" scale-alert 6, designating the Influenza
H1N1 2009 a potential threat to worldwide health (5)
and declared the outbreak as Public Health Emergency
of  International Concern. In India with increasing number
of total confirmed cases deaths the threat of a full blown
epidemic in India is very real.If we look at the countries
being first and most affected, Probably they are otherwise
in the hit list and are being continuously targeted by the
world terrorist organizations. This remains the question/
matter of investigation for the world security agencies.
There are other reasons also to have high level of
suspicion for  the current pandemic to be investigated on
the line of bioterrorism attempt.H1N1 Virus is highly
infectious and highly effective in producing pathology,
efficiently dispersible, readily grown and produced in large
quantities, can be spread to others within 6 feet of an ill
person who is a confirmed, probable or suspected case
of swine influenza A (H1N1) virus infection during the
infectious period. Resistant enough to environmental
conditions and detrimental in particular season. It can
cause high mortality to high-risk group ie elderly people,
very young children and pregnant ladies and people with
certain chronic health conditions (chronic heart or lung,
metabolic or renal diseases or immunodeficiencies).
Patients remain infectious for 1 day prior to the onset of
illness to 7 days after onset. Human-to-human
transmission of swine flu can also occur in the same way
as seasonal flu through coughing or sneezing by infected
people.Disease spreads very quickly among the
population especially in crowded places. Cold and dry
weather enables the virus to survive longer outside the
body than in other conditions and as a consequence,
seasonal epidemics in temperate areas appear in winter.
People may become infected by touching/handling things
contaminated with flu viruses on it and then touching their
mouth or nose (6).
Clinical presentation mimics the normal flu. The
symptoms of swine flu are expected to be similar to the
symptoms of regular human seasonal influenza like fever,
lethargy, lack of appetite and cough. Though some people
have also reported runing of nose, sore throat, nausea,
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vomiting and diarrhea. This can pose diagnosis difficulty
unless high level of suspicion is adopted by the treating
doctor, at the same time if high level of suspicion is
adopted, it is going to create panic and increase work
load at laboratories and in hospitals and indirectly going
to affect economy of the nation/state (6).
Currently, there is limited capability to detect this agent
ie no simple and fast methods for an early detection are
available. Real Time PCR, Viral culture, Four-fold rise in
swine influenza A (H1N1) virus specific neutralizing
antibodies are the recommended laboratory investigation,
which remain inaccessible to all. Only few centers are
available in our country having the  infrastructure to carry
these test. Moreover, the cost of these test is high
(Rs10,000 to 15,000) and is a ecnomic threat for the poor
population (6).
The licensed anti-influenza drugs (the M2 ion channel
blockers, amantadine, rimantadine and the neuraminidase
inhibitors, oseltamivir and zanamivir) are beneficial for
uncomplicated seasonal influenza.Ribavirin has also been
used to a limited extent to treat influenza. Parenterally
administered neuraminidase inhibitors, peramivir and
zanamivir; dimeric forms of zanamivir; the RNA
polymerase inhibitor T-705; a ribavirin prodrug, viramidine;
polyvalent and monoclonal antibodies; and combination
therapies are under trials (7, 8).
Thus, very few treatment options available. Moreover,
treatment options may be limited by the rapid emergence
of drug-resistant viruses. Oseltamivir is only available
recommended for H1NI virus and appear effective (8)
but have a great threat for resistance to treatment.
Oseltamivir-resistant influenza viruses A (H1N1) (ORVs)
with H275Ymutation in the neuraminidase emerged
independently of drug use ranging from 0% to 68%, with
the highest proportion in Norway (9-10).
There is currently no vaccine available against
H1NI influenza. However, is are under trial. Not much
of bio-safety guidelines are available across the world
for effective prevention and control of the virus and
antiviral prophylaxis accept guidelines of Australia and
Newzland and WHO (5, 8).
 Terrorism is psychological warfare. "Kill one, Frighten
Ten Thousand". Bio-chemical terrorism is not a new
phenomenon (11). Thus, posibility of non-conventional
attack by terrorists must not be ruled out straightway
without investigating it thoroughly by the security agencies
across the world. As H1N1 appears to be audacious,
potent and dramatic to have achieved "Unthinkable". The
present episode of outbreak has created widespread
sense of fear, anxiety and panic as well as has been able
to generate an individual sense of helplessness,
vulnerability and hopelessness and able to  demonstrate
the incompetence and/or inability of the authorities to
afford complete protection against such an outbreak. It
has also led to provoke the authorities and general public
to commit errors or overreactions in their daily deeds.
Thus, current Swine Flu H1NI outbreak a natural
Pandemic or attack of Bioterrorism is a matter of
debate.The assumption  need investivation in the interest
of human security.
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